Department of Microbiology, Harvard Medical School, Boston, Massachusetts 02115, United States.
Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.
J Am Chem Soc. 2024 Sep 25;146(38):26320-26330. doi: 10.1021/jacs.4c08656. Epub 2024 Sep 14.
-GlcNAc transferase (OGT) is an essential mammalian enzyme that binds thousands of different proteins, including substrates that it glycosylates and nonsubstrate interactors that regulate its biology. OGT also has one proteolytic substrate, the transcriptional coregulator host cell factor 1 (HCF-1), which it cleaves in a process initiated by glutamate side chain glycosylation at a series of central repeats. Although HCF-1 is OGT's most prominent binding partner, its affinity for the enzyme has not been quantified. Here, we report a time-resolved Förster resonance energy transfer assay to measure ligand binding to OGT and show that an HCF-1-derived polypeptide (HCF3R) binds with picomolar affinity to the enzyme ( ≤ 85 pM). This high affinity is driven in large part by conserved asparagines in OGT's tetratricopeptide repeat domain, which form bidentate contacts to the HCF-1 peptide backbone; replacing any one of these asparagines with alanine reduces binding by more than 5 orders of magnitude. Because the HCF-1 polypeptide binds so tightly to OGT, we tested its ability to inhibit enzymatic function. We found that HCF3R potently inhibits OGT both in vitro and in cells and used this finding to develop a genetically encoded, inducible OGT inhibitor that can be degraded with a small molecule, allowing for reversible and tunable inhibition of OGT.
糖基转移酶(OGT)是一种重要的哺乳动物酶,可结合数千种不同的蛋白质,包括其糖基化的底物和调节其生物学功能的非底物相互作用因子。OGT 还有一个蛋白水解底物,即转录共调节剂宿主细胞因子 1(HCF-1),它在谷氨酸侧链糖基化启动的一系列核心重复序列中被切割。尽管 HCF-1 是 OGT 最突出的结合伴侣,但它与酶的亲和力尚未被量化。在这里,我们报告了一种时间分辨的Förster 共振能量转移测定法,以测量配体与 OGT 的结合,并表明 HCF-1 衍生的多肽(HCF3R)以皮摩尔亲和力结合到该酶(≤85 pM)。这种高亲和力主要是由 OGT 的四肽重复结构域中的保守天冬酰胺驱动的,这些天冬酰胺与 HCF-1 肽骨架形成双齿接触;用丙氨酸取代这些天冬酰胺中的任何一个都会使结合降低 5 个数量级以上。由于 HCF-1 多肽与 OGT 结合如此紧密,我们测试了它抑制酶功能的能力。我们发现 HCF3R 可在体外和细胞内强烈抑制 OGT,并利用这一发现开发了一种可遗传编码的、可诱导的 OGT 抑制剂,可被小分子降解,从而实现 OGT 的可逆和可调抑制。